Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on December 9, 2008
Dec 04, 2008 08:06 AM
- Participants at Comintell's User Conference Learn How to Succeed With Intelligence Software
Oct 14, 2008 09:58 AM
- Hi-Tech Pharmacal to Present at the UBS Global Life Sciences Conference
Sep 19, 2008 09:56 AM
- Hi-Tech Pharmacal Reports First Fiscal Quarter Results
Sep 08, 2008 08:16 AM
- Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 8, 2008
Sep 03, 2008 11:17 AM
- Hi-Tech Pharmacal Files Suit to Confirm the Company's Market Exclusivity Status Regarding Dorzolamide and Timolol Ophthalmic Solution
Aug 28, 2008 11:46 AM
- Hi-Tech Pharmacal Reports Strong Sales and a Return to Profitability for the Fourth Fiscal Quarter 2008
Jul 11, 2008 08:10 AM
- Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 11, 2008
Jul 07, 2008 08:32 PM
- Hi-Tech Pharmacal to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
May 23, 2008 10:57 AM
- Hi-Tech Pharmacal Launches Authorized Generic of Warner Chilcott's Dovonex(R) Scalp Solution
May 09, 2008 09:26 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
HITK
|
Compare to S&P
|
| YTD |
-64.06 %
|
-0.01 %
|
| 4 Weeks |
-48.60 %
|
-43.76 %
|
| 12 Weeks |
-65.48 %
|
-51.16 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -950.00 %
|
|
EPS Growth in Last Year: 32.00 %
|
|
Sales Growth in Last Quarter: -24.69 %
|
|
Sales Growth in Last Quarter: 56.39 %
|
|
|
